BJDXHealthcareNano-Cap
Bluejay Diagnostics, Inc. Insider Trading Activity
Every SEC Form 4 insider transaction reported for Bluejay Diagnostics, Inc. (BJDX), sourced directly from SEC EDGAR and updated as new filings are accepted.
By Trabud Research Team · SEC Form 4 & insider trading data analysts
Last updated:
Quick Answer
Are BJDX insiders buying or selling?
Bluejay Diagnostics, Inc. insiders reported 17 open-market buys ($367.9K) and 0 sells ($0) across 17 Form 4 filings — a net buying position of $367.9K.
Source: SEC EDGAR Form 4
Key Statistics (as of Jul 13, 2026)
Total Form 4 filings
17
SEC EDGAR
Insider filers
8
Insider buys (17)
$367.9K
Insider sells (0)
$0
Insider sentiment
Net buyingNet insider flow of $367.9K in net buying. 6 insider buys in the last 90 days.
Recent BJDX insider transactions
| Date | Insider | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jul 13, 2026 | HRT FINANCIAL LP | 10% Owner | Purchase | 29.1K | $1.64 | $47.8K |
| May 18, 2026 | Wurth Douglas Clark | Director | Purchase | 12.5K | $2.00 | $25.0K |
| May 18, 2026 | Dey Indranil | President and CEO | Purchase | 12.5K | $2.00 | $25.0K |
| May 18, 2026 | Donald R Chase | Director | Purchase | 12.5K | $2.00 | $25.0K |
| May 18, 2026 | ZEIDMAN FRED S | Director | Purchase | 12.5K | $2.00 | $25.0K |
| May 18, 2026 | Svetlana Dey | Director | Purchase | 12.5K | $2.00 | $25.0K |
| Dec 14, 2023 | Svetlana Dey | Director | Purchase | 500 | $3.07 | $1.5K |
| Dec 14, 2023 | Dey Indranil | President and CEO | Purchase | 500 | $3.27 | $1.6K |
| Mar 31, 2023 | Svetlana Dey | Director | Purchase | 10.0K | $0.44 | $4.4K |
| Mar 31, 2023 | Dey Indranil | President and CEO | Purchase | 10.0K | $0.44 | $4.4K |
| Sep 7, 2022 | Kenneth R Fisher | Chief Financial Officer | Purchase | 20.0K | $1.03 | $20.6K |
| Apr 27, 2022 | Kenneth R Fisher | Chief Financial Officer | Purchase | 20.0K | $0.99 | $19.8K |
| Mar 21, 2022 | Gordon Winston Kinder | Chief Financial Officer | Purchase | 2.5K | $1.16 | $2.9K |
| Mar 21, 2022 | Svetlana Dey | Director, 10% Owner | Purchase | 10.0K | $1.18 | $11.8K |
| Mar 18, 2022 | Wurth Douglas Clark | Director, 10% Owner | Purchase | 40.0K | $1.18 | $47.1K |
| Mar 17, 2022 | Wurth Douglas Clark | Director, 10% Owner | Purchase | 60.0K | $1.09 | $65.4K |
| Mar 17, 2022 | Gordon Winston Kinder | Chief Financial Officer | Purchase | 16.0K | $0.97 | $15.5K |
Showing the 17 most recent of 17 Form 4 filings for Bluejay Diagnostics, Inc..
Most active BJDX insiders
- Svetlana Dey4 filings
- Dey Indranil3 filings
- Wurth Douglas Clark3 filings
- Gordon Winston Kinder2 filings
- Kenneth R Fisher2 filings
Ask anything about BJDX insider activity
Use Trabud's AI agent to query Bluejay Diagnostics, Inc.'s Form 4 history in plain English — "Show me BJDX CEO purchases this year" or compare it against any other ticker.
Open the AI agentBJDX insider trading FAQ
Are Bluejay Diagnostics, Inc. insiders buying or selling?
Across 17 SEC Form 4 filings, Bluejay Diagnostics, Inc. (BJDX) insiders reported 17 open-market purchases totaling $367.9K and 0 sales totaling $0. That is a net buying position of $367.9K.
How many insiders trade BJDX stock?
8 distinct insider filers — officers, directors, 10%+ owners, and investment groups filing jointly — have reported Form 4 transactions for Bluejay Diagnostics, Inc.. The most recent filing was accepted on Jul 13, 2026.
Where does Trabud get BJDX insider trading data?
All BJDX insider trading data comes directly from official SEC EDGAR Form 4 filings, which corporate insiders must submit within two business days of a transaction under Section 16(a) of the Securities Exchange Act of 1934.
Looking for another company? Browse all tracked companies.